Stockreport

YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024

YS Biopharma Co., Ltd. - Ordinary Shares  (YS) 
PDF GAITHERSBURG, Md., April 19, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to [Read more]